Figure 3

Hazard ratios and 95% confidence interval for all-cause and cardiovascular mortality associated with lipid biomarkers in categories among people aged 39–59 years (left), 60–79 years (middle), and ≥ 80 years (right), respectively, adjusted for age, sex, and history of coronary heart disease, heart failure, atrial fibrillation, hypertension, diabetes, ischemic stroke, and transient ischemic attack.